Update on Bidco’s Financing Arrangements

Intertek’s £ multi-billion acquisition financing is now fully secured and interim facilities cancelled.

What the company is saying

Intertek Group PLC confirms that Isotope Bidco Limited, backed by EQT X EUR SCSp, EQT X USD SCSp, Luxinva, and Mubadala, has executed all definitive financing agreements for the recommended cash acquisition of Intertek. The announcement details the completion of a senior facilities agreement on 9 October 2026, which includes a EUR 1,570,000,000 term loan, an AUD 350,000,000 term loan, and a USD 2,720,000,000 term loan, all arranged with Barclays Bank PLC as agent and security agent. On the same date, Isotope Finco S.à r.l. and Isotope Finco 2, LLC co-issued EUR 435,000,000 and USD 700,000,000 in senior secured fixed rate notes, with Deutsche Bank Trustee Company Limited as trustee. The company emphasizes that the interim facilities previously in place have been cancelled in full and are no longer effective as of 9 October 2026. Legal and financial advisers for all parties are named, underscoring the institutional weight behind the transaction. The tone is procedural, with a focus on the finality of the acquisition terms, except in the event of a competing offer or regulatory consent.

What the data suggests

The financing package for the Intertek acquisition is now fully committed, with a total of EUR 1,570,000,000, AUD 350,000,000, and USD 2,720,000,000 in new term loans secured under the senior facilities agreement. In addition, EUR 435,000,000 and USD 700,000,000 in senior secured fixed rate notes have been issued, providing further funding certainty. The cancellation of the interim facilities removes any bridging risk and signals that long-term capital is now in place. All agreements were executed on 9 October 2026, and the counterparties include major global banks and institutional investors, which supports the credibility of the financing. The announcement does not provide operational, revenue, or profitability figures for Intertek itself, focusing solely on the mechanics and completion of the acquisition financing. The data is comprehensive for its stated purpose but does not address the underlying business trajectory or integration plans.

Analysis

The announcement is a factual update on the financing arrangements for the acquisition of Intertek Group PLC, detailing the execution of new senior facilities and the issuance of senior secured notes. All key claims are supported by specific, realised actions (signed agreements, issued notes, cancelled interim facilities), with only a single forward-looking statement regarding the finality of the acquisition terms in the event of a competing offer. There is no promotional or exaggerated language; the tone is strictly procedural and legalistic. While the transaction is capital intensive, the announcement does not speculate on future synergies, returns, or operational benefits, nor does it attempt to frame the financing as an immediate value driver. No operational or profitability metrics are disclosed, but this is appropriate given the announcement's focus on transaction mechanics rather than business performance. There is no gap between narrative and evidence, and no hype is present.

Risk flags

• ●The transaction introduces substantial leverage, with over EUR 1.5 billion, AUD 350 million, and USD 2.7 billion in new term loans, plus EUR 435 million and USD 700 million in senior secured notes, which will materially increase the debt burden of the post-acquisition entity. Elevated leverage can constrain future financial flexibility and increase refinancing risk if market conditions deteriorate.
• ●The acquisition is subject to completion of a court-sanctioned scheme of arrangement and may still require regulatory or shareholder approvals. Any delay or failure at these procedural steps could jeopardize deal closure, despite the financing now being in place.
• ●The announcement does not address integration, synergy realization, or operational plans post-acquisition, leaving uncertainty about how the enlarged group will deliver value or manage the increased debt load. This lack of operational disclosure is a material information gap for investors.
• ●While the financial terms are stated as final, the company reserves the right to increase the offer in the event of a competing bid or with Panel consent, introducing potential uncertainty around final deal economics and timeline.
• ●The involvement of multiple institutional investors, including EQT, Luxinva, and Mubadala, signals strong backing, but their participation does not guarantee ongoing support or operational success post-acquisition.

Bottom line

Intertek’s acquisition by Isotope Bidco Limited is now fully financed, with over EUR 1.5 billion, AUD 350 million, and USD 2.7 billion in new term loans, and an additional EUR 435 million and USD 700 million in senior secured notes issued. The cancellation of interim facilities eliminates near-term funding risk, and the transaction is backed by major institutional investors and global banks, lending credibility to execution. However, the announcement provides no detail on operational integration, synergy targets, or how the enlarged group will manage its significantly higher debt load. The only remaining hurdles are procedural—court, regulatory, and shareholder approvals—which are expected in the near term. Investors should focus on the implications of the new leverage and watch for future disclosures on integration and performance. The most important takeaway is that the acquisition’s funding is now locked in, but operational and value-creation details remain undisclosed.

Announcement summary

(LSE:ITRK) Intertek Group PLC announced an update on the financing arrangements for the recommended final cash acquisition by Isotope Bidco Limited, a newly formed company to be indirectly owned by EQT X EUR SCSp and EQT X USD SCSp, with certain indirect minority shareholders including Luxinva and Mubadala. The acquisition, to be implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006, covers the entire issued and to be issued ordinary share capital of Intertek. On 9 October 2026, Isotope Finco S.à r.l. and certain subsidiaries entered into a senior facilities agreement with original lenders, Barclays Bank PLC as agent and security agent, comprising a euro denominated term loan of EUR 1,570,000,000, an Australian dollar denominated term loan of AUD 350,000,000, and a US Dollar denominated term loan of USD 2,720,000,000. On the same date, Isotope Finco S.à r.l. and Isotope Finco 2, LLC co-issued EUR 435,000,000 of senior secured fixed rate notes and USD 700,000,000 of senior secured fixed rate notes pursuant to an indenture dated 9 October 2026, with Deutsche Bank Trustee Company Limited as trustee. An intercreditor agreement was also entered into with the original senior lenders, Deutsche Bank Trustee Company Limited, and Barclays Bank PLC. The Interim Facilities Agreement and the interim facilities thereunder have been cancelled in their entirety and are no longer in effect as of 9 October 2026. Copies of the relevant documents have been made available on Bidco's and Intertek's websites, subject to certain restrictions. The financial terms of the acquisition are final and will not be increased, except in specific circumstances such as a competing offer or with Panel consent. Legal advisers to the parties include Freshfields LLP for EQT and Bidco, Simpson Thacher & Bartlett LLP and Advokatfirman Vinge KB as regulatory counsel to Bidco, Linklaters LLP for Luxinva, Clifford Chance LLP for Mubadala, and Slaughter and May for Intertek. Financial advisers include Morgan Stanley, Barclays, and Deutsche Bank for Bidco, and Goldman Sachs International, J.P. Morgan Cazenove, and PJT Partners for Intertek. Communications advisers are FGS Global for Bidco and DGA for Intertek.

Disagree with this article?